CN Patent

CN110922409A — 制备btk抑制剂泽布替尼的方法

Assigned to Wuhan Jiuzhou Yumin Medical Technology Co ltd · Expires 2020-03-27 · 6y expired

What this patent protects

本发明涉及一种制备BTK抑制剂泽布替尼的方法。本发明所述的方法，其使用易得到的、价格便宜的中间体，经过5步反应得到目标产物。

USPTO Abstract

本发明涉及一种制备BTK抑制剂泽布替尼的方法。本发明所述的方法，其使用易得到的、价格便宜的中间体，经过5步反应得到目标产物。

Drugs covered by this patent

Patent Metadata

Patent number
CN110922409A
Jurisdiction
CN
Classification
—
Expires
2020-03-27
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Jiuzhou Yumin Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.